Coupled equilibria of dimerization and lipid binding modulate SARS Cov 2 Orf9b interactions and interferon response.
Saved in:
| Title: | Coupled equilibria of dimerization and lipid binding modulate SARS Cov 2 Orf9b interactions and interferon response. |
|---|---|
| Authors: | San Felipe CJ; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, United States., Batra J; Quantitative Biosciences Institute, University of California, San Francisco, San Francisco, San Francisco, United States.; Gladstone Institute of Data Science and Biotechnology, J. David Gladstone Institutes, San Francisco, United States.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, United States., Muralidharan M; Quantitative Biosciences Institute, University of California, San Francisco, San Francisco, San Francisco, United States.; Gladstone Institute of Data Science and Biotechnology, J. David Gladstone Institutes, San Francisco, United States.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, United States., Malpotra S; Quantitative Biosciences Institute, University of California, San Francisco, San Francisco, San Francisco, United States.; Gladstone Institute of Data Science and Biotechnology, J. David Gladstone Institutes, San Francisco, United States.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, United States., Anand D; Quantitative Biosciences Institute, University of California, San Francisco, San Francisco, San Francisco, United States.; Gladstone Institute of Data Science and Biotechnology, J. David Gladstone Institutes, San Francisco, United States.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, United States., Bauer R; Quantitative Biosciences Institute, University of California, San Francisco, San Francisco, San Francisco, United States.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, United States., Verba KA; Quantitative Biosciences Institute, University of California, San Francisco, San Francisco, San Francisco, United States.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, United States., Swaney DL; Quantitative Biosciences Institute, University of California, San Francisco, San Francisco, San Francisco, United States.; Gladstone Institute of Data Science and Biotechnology, J. David Gladstone Institutes, San Francisco, United States.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, United States., Krogan NJ; Quantitative Biosciences Institute, University of California, San Francisco, San Francisco, San Francisco, United States.; Gladstone Institute of Data Science and Biotechnology, J. David Gladstone Institutes, San Francisco, United States.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, United States., Grabe M; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, United States., Fraser JS; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, United States.; Quantitative Biosciences Institute, University of California, San Francisco, San Francisco, San Francisco, United States. |
| Source: | ELife [Elife] 2025 Sep 17; Vol. 14. Date of Electronic Publication: 2025 Sep 17. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: eLife Sciences Publications, Ltd Country of Publication: England NLM ID: 101579614 Publication Model: Electronic Cited Medium: Internet ISSN: 2050-084X (Electronic) Linking ISSN: 2050084X NLM ISO Abbreviation: Elife Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
